28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
Clinical trial NCT05358821 · COMPLETED
Trial details
- NCT number
- NCT05358821
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2024-02-29
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.